Polydatin for treating spinal cord injury: Multiple mechanisms and challenges

Area of Science:

• Neuroscience
• Pharmacology
• Traditional Chinese Medicine

Background:

• Spinal cord injury (SCI) is a severe neurological condition with high disability and mortality rates.
• Current therapies for SCI are limited by complex pathological mechanisms.
• Natural compounds, like polydatin (PD) from Polygonum cuspidatum, are gaining attention for therapeutic potential.

Purpose of the Study:

• To explore the feasibility of using polydatin (PD) for spinal cord injury (SCI) treatment.
• To elucidate the pathophysiological processes of SCI and PD's molecular mechanisms.
• To discuss strategies for enhancing PD's bioavailability and delivery for SCI.

Main Methods:

• Literature review on SCI pathophysiology.
• Analysis of polydatin's (PD) pharmacological actions (anti-inflammatory, antioxidant, anti-apoptotic, neuroprotective).
• Examination of PD's molecular mechanisms in SCI models.
• Review of drug delivery systems and bioavailability enhancement for PD.

Main Results:

• Polydatin (PD) exhibits significant anti-inflammatory, antioxidant, anti-apoptotic, and neuroprotective effects relevant to SCI.
• Structural similarities and differences between PD and resveratrol are noted.
• PD demonstrates potential in mitigating SCI-induced damage through various molecular pathways.

Conclusions:

• Polydatin (PD) presents a promising therapeutic agent for spinal cord injury (SCI) due to its multifaceted protective effects.
• Improving PD's bioavailability and utilizing advanced drug delivery systems are crucial for its clinical application in SCI.
• Further research into PD's challenges and prospects is warranted for effective SCI treatment.